FierceBiotech 12. Feb. 2026 Sanofi ousts Paul Hudson after ‘bumpy ride’, poaches Merck KGaA CEO to lead the French pharma
FierceBiotech 10. Feb. 2026 Merck teams up with British medtech to boost vaginal therapeutics delivery system
FierceBiotech 19. Dez. 2025 Merck turns down option to Evaxion's gonorrhea vaccine, prompting Danish biotech to seek other partners
Endpoints News 18. Dez. 2025 Daiichi and Merck's I-Dxd lung cancer study faces partial hold due to deaths
FierceBiotech 9. Dez. 2025 ASH: Merck mulls future of polycythemia program while Takeda takes phase 3 victory lap
Endpoints News 5. Dez. 2025 German court stops Merck from selling subcutaneous Keytruda in patent battle with Halozyme